RUNDC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.7715611723761E-16 |
Normal-vs-Stage2 |
1.51856305308229E-12 |
Normal-vs-Stage3 |
1.62447832963153E-12 |
Normal-vs-Stage4 |
1.62447832963153E-12 |
Stage1-vs-Stage2 |
3.078000E-01 |
Stage1-vs-Stage3 |
3.79070000000592E-06 |
Stage1-vs-Stage4 |
3.228200E-04 |
Stage2-vs-Stage3 |
1.097190E-01 |
Stage2-vs-Stage4 |
1.024160E-01 |
Stage3-vs-Stage4 |
9.043400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62447832963153E-12 |
Normal-vs-AfricanAmerican |
5.80600012511923E-11 |
Normal-vs-Asian |
3.214400E-02 |
Caucasian-vs-AfricanAmerican |
1.875170E-01 |
Caucasian-vs-Asian |
3.589500E-02 |
AfricanAmerican-vs-Asian |
2.689400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62436730732907E-12 |
Normal-vs-Female |
1.62436730732907E-12 |
Male-vs-Female |
2.2785999997943E-07 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.54289914178207E-11 |
Normal-vs-Age(41-60Yrs) |
<1E-12 |
Normal-vs-Age(61-80Yrs) |
<1E-12 |
Normal-vs-Age(81-100Yrs) |
2.70219999709553E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.522590E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.403640E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.796000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.741200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.883600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.395800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.943400E-03 |
Normal-vs-Grade 2 |
1.62592161956354E-12 |
Normal-vs-Grade 3 |
1.6242562850266E-12 |
Normal-vs-Grade 4 |
1.62436730732907E-12 |
Grade 1-vs-Grade 2 |
2.533600E-01 |
Grade 1-vs-Grade 3 |
6.588000E-02 |
Grade 1-vs-Grade 4 |
1.780240E-02 |
Grade 2-vs-Grade 3 |
5.367700E-04 |
Grade 2-vs-Grade 4 |
4.89070000053715E-08 |
Grade 3-vs-Grade 4 |
1.164240E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.77555756156289E-15 |
Normal-vs-ccB subtype |
1.62447832963153E-12 |
ccA subtype-vs-ccB subtype |
2.0361999999996E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
<1E-12 |
Normal-vs-N1 |
6.79490019805939E-10 |
N0-vs-N1 |
6.239600E-01 |
|
|